Lupronejim, I hope your IHT will go smooth and remember Provenge didn't stop to work with last infusion but it will continue to work inside you no for days or months, but years. It slow down growth...
[b]Gomella Discusses Optimizing Sipuleucel-T in mCRPC Laura Martin @OncEditorLaura Published Online: Monday, March 16, 2015 Dr. Leonard G. Gomella Leonard G. Gomella, MD In the nearly 5 years since...
From Onclive: "Dendreon Revenue Rises, Despite Restructuring Silas Inman @silasinman Published Online: Wednesday, January 14, 2015 Increased utilization of the autologous cellular immunotherapy...
Recently I read interesting scientific article from Yale Journal of Biology and Medicine "Yale J Biol Med. Dec 2014; 87(4): 481–489. Published online Dec 12, 2014. PMCID: PMC4257035 Focus: Vaccines...
LupronJim, I hope everything going smooth with your Provenge process ( don't count this little hiccup ). One more week and you finished it. I received ( 2 days ago) email from Prostate Cancer...
Quincy17, It is so wonderful you could receive Provenge , when your PSA was 134 ng/mL) baseline PSA values not only generally lived longer, but also achieved a greater benefit with Provenge....
A little titbits From PCRI2014 ( special about Provenge); [blue]Basics treatment Principles relapsed and advanced disease : - PSA rise after ]surgery or radiation should trigger disease reevalution...
Quincy17, So sorry to hear that your PSA is rising. Challenge with Provenge - PSA usually continue to rice in many patients after treatment (l 49packard) but in some cases it can fall ( for example...
[b]Sipuleucel-T Helps ADT Boost Prostate Cancer Immunity Beth Fand Incollingo Published Online: Thursday, August 28, 2014 Emmanuel S. Antonarakis, MBBCh [b][4]Sipuleucel-T (Provenge) is effective...
Kayak808 and LupronJim, sorry that it is take so long for me to answer your questions. It was very busy summer for me and I didn't visit this site for almost 2 months. My apology to both of you....
Clinical Advances in Hematology & Oncology Volume 11, Issue 10 May 2014 Prostate Cancer [blue]The Potential Role of Antigen Spread in Immunotherapy for Prostate Cancer Charles G. Drake, MD, PhD...
[blue]Immunotherapy in Cancer Care: Understanding the Impact of Shifting Treatment Paradigms in the Managed Care Setting Panelists discussed the positive and negative aspects of using immunotherapy,...
From ASCO2014: [green]"Effect of combined sequential treatment of sipuleucel-T followed by enzalutamide in metastatic chemotherapy-naive castration resistant prostate cancer: Results of single center...
This data are not representative of the typical US patient. Over 70% had no local therapy. Only 20% had radical prostatectomy. It is benefit patients in high volume disease at entry. Patients with...
Maybe in the second half of this year, Provenge will be available to prostate cancer patients in Europe ( starting in Germany and UK ). There is interesting research paper: "Optimal management of...
I think it will be interesting some tidbits from AACR( American Association for Cancer Research ) Annual Meeting 2014 , April 5-9, 2014 , San Diego : Immunotherapy in Cancer is prominent at this...
April 11, 2014 [blue]Immune Responses Enhanced and Sustained When PROVENGE® (sipuleucel-T) is Given After Androgen Deprivation Therapy in Biochemically-Recurrent Prostate Cancer Preliminary data from...
Kayak808, First I would like repost Abstract #4650 from your link: " Abstract #4650: [blue]Correlation of Increased Eosinophil Count Following Sipuleucel-T Treatment with Outcome in Patients (pts)...
[blue]A Conversation With Dr. Paul Schellhammer Posted April 8, 2014 Filed under: Uncategorized | Dr. Paul SchellhammerProstate Forum recently spoke with Dr. Paul Schellhammer, a urologic oncologist...
[blue]Immunotherapy Biomarkers and Combinations Needed in CRPC: An Interview With Padmanee Sharma, MD, PhD Published Online: Tuesday, April 8, 2014 "The field of immunotherapy continues to evolve...
Devasted1, You maybe will be interesting to read follow abstract ( it is from your trial NEOACT PROVENGE ) that will be presented at Annual meeting AACR 20014 ( American Association for Cancer...
LupronJim and Redheadskier, This trial will be for for men with castration-resistant prostate cancer. No yet information abot this trial on official website for trials. It will be good idea to...
[blue]Dr. Sartor on Provenge in Combination with Radium-223 Oliver Sartor, MD Published Online: Tuesday, April 1, 2014 Oliver Sartor, MD, board professor, cancer research, Tulane University,...
[blue]Immunotherapies Promising But Still Challenging in CRPC Sandra Kear Published Online: Monday, March 17, 2014 Dr Robert Dreicer Robert Dreicer, MD, MS Increasing efficacy with immunotherapies...
JCRush, Congratulation with such great result! Usually drop in PSA is rare after Provenge, special so quick ( we know Provenge alter PSADT) , but your response is excellent. Kudos to your doctor also...
[blue][4]Dramatic cancer reversals like this with Provenge therapy By Mark Scholz, M.D. Prostate Oncology Specialists [blue]The Effect of Radiation on the Immune System In general, the word...
Devasted1, I don't think we will see additional information for your study. The primary purpose of it : To assess the immune response within prostate tissue following neoadjuvant treatment with...
Devasted1, In your study Provenge was used before the prostate was surgically removed and after prostatectomy researches looked at prostate, they found the T-cells had completely surrounded the tumor...
Patient Power just posted some interesting videos about Provenge : Current Treatment Options for Metastatic, Castrate-Resistant Prostate Cancer Topics include: Treatment Published on February 12,...
Congratulation ! I hope you will report like 49packard that it is the easiest and best treatment you ever take during your PC journey and has been the best you've felt since dx. I wish you don't need...
Dr. Gomella Discusses New Data on Sipuleucel-T Leonard Gomella, MD Published Online: Friday, January 31, 2014 Leonard Gomella, MD, chair, Department of Urology, director, Kimmel Cancer Center...
Vaccines vs. Immune Checkpoint Inhibitors January 31, 2014 [4]Dr. Charles Drake: Prostate cancer is the only disease for which cancer vaccine is approved in a treatment setting. It’s interesting...
[4]Using Immunotherapy for Metastatic Solid Tumors: Unique Mechanisms of Action Offer Promise January 30, 2014 By James L. Gulley, MD, PhD, FACP The approach to cancer treatment for metastatic solid...
Combination vs. Single Agent Sequential Systemic Therapies in Men with mCRPC: The Cost of Unanswered Questions January 30, 2014 By Andrew J. Armstrong, MD, ScM, Michael R. Harrison, MD and Daniel J....
LuvMyDAD, you said : "I was reading the survival statistics of provenge and it seemed to only prolong life by an average of 4 months. Is it safe to assume that others will have a more of a favorable...
[blue]Engaging the Immune System in Dynamic Therapy to Match the Evolutionary Evasive Properties of Prostate Cancer. Authors:Ravi A. Madan, MD, and James L. Gulley, MD, PhD, FACP Recent years have...
Good luck you both Kwidd and Samham55 The best Hope...
49packard, Just remember that the inhibitory effect of Provenge results in a progressively longer survival when its effects are allowed to accumulate over a longer lifespan. You still continue to...
49packard, I hope your doctor has plan for you what to do next. Still there are a lot of treatments that can give you many years ahead. You maybe will be interesting look at Dr. Mark Scholz plan...
Jerry L., I am sorry for posting on this threat ( I didn't have Provenge treatment), but I would like to point you a little mistake on your chart and think you maybe would like to correct it....
49packard, Hope this trend continue for you in 2014. I am making resolution for you for 2014: You PSA continue to drop or never go more then 100 and so your PSAD continue to be > 18 months; You don't...
Marie Huber is just the top of the iceberg of those powerful who try to put Provenge on the shelf and damage the company so badly that could drive it to bankruptcy. She is not so powerful to do it...
SteelGuy, Good that you and your doctors decide that next step for you is Provenge. And If you will continue to have difficulties with your insurance company you maybe will consider explore this...
49packard, It looks like your cancer is stabilized, PSA is slowing down and PSADT time is taking longer. It is very good. And remember Provenge continue to work inside you. If your doctor decided no...
Congratulations, My best, Hope...
On 10/28/2013 Urotoday posted : "The Immunotherapy for Prostate Adenocarcinoma Treatment (IMPACT) trial: Lower baseline prostate-specific antigen Is associated with a greater overall survival benefit...
I don't want to go again there . Look at those doctors connection. But better read this: http://www.deepcapture.com/wp-content/uploads/story-of-dendreon.pdf I t is why sometimes "big boys" go to...
John T, I am not a cynical. I try to stay with science. But follow Provenge from 2007 , unfortunately open my eyes on many things. My best to you. Hope...
On this threat I posted videolecture : "Immunotherapy in a mCRPC patient: The large urology group experience " by Dr. Christopher Pieczonka. You can read about it on page 8 ( 8/20/2013). Several days...
If none of us know about the finances but only the technology what would we think it should be worth? Immunotherapy is a future and maybe in the next 10-20 years Provenge still could be the best and...